1. Home
  2. HALO vs UGI Comparison

HALO vs UGI Comparison

Compare HALO & UGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • UGI
  • Stock Information
  • Founded
  • HALO 1998
  • UGI 1940
  • Country
  • HALO United States
  • UGI United States
  • Employees
  • HALO N/A
  • UGI N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • UGI Natural Gas Distribution
  • Sector
  • HALO Health Care
  • UGI Utilities
  • Exchange
  • HALO Nasdaq
  • UGI Nasdaq
  • Market Cap
  • HALO 7.4B
  • UGI 6.9B
  • IPO Year
  • HALO N/A
  • UGI N/A
  • Fundamental
  • Price
  • HALO $50.13
  • UGI $34.68
  • Analyst Decision
  • HALO Buy
  • UGI Buy
  • Analyst Count
  • HALO 9
  • UGI 2
  • Target Price
  • HALO $63.78
  • UGI $27.50
  • AVG Volume (30 Days)
  • HALO 2.1M
  • UGI 2.1M
  • Earning Date
  • HALO 05-06-2025
  • UGI 05-07-2025
  • Dividend Yield
  • HALO N/A
  • UGI 4.36%
  • EPS Growth
  • HALO 55.40
  • UGI N/A
  • EPS
  • HALO 3.76
  • UGI 2.46
  • Revenue
  • HALO $1,084,306,000.00
  • UGI $7,318,000,000.00
  • Revenue This Year
  • HALO $20.06
  • UGI $6.20
  • Revenue Next Year
  • HALO $24.20
  • UGI $8.02
  • P/E Ratio
  • HALO $17.71
  • UGI $13.96
  • Revenue Growth
  • HALO 25.64
  • UGI N/A
  • 52 Week Low
  • HALO $41.28
  • UGI $22.01
  • 52 Week High
  • HALO $70.51
  • UGI $34.49
  • Technical
  • Relative Strength Index (RSI)
  • HALO 36.86
  • UGI 65.83
  • Support Level
  • HALO $58.38
  • UGI $34.32
  • Resistance Level
  • HALO $69.94
  • UGI $35.35
  • Average True Range (ATR)
  • HALO 3.06
  • UGI 0.63
  • MACD
  • HALO -0.11
  • UGI 0.20
  • Stochastic Oscillator
  • HALO 6.60
  • UGI 76.59

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About UGI UGI Corporation

UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.

Share on Social Networks: